Option Care Health (OPCH) Competitors $30.07 -0.96 (-3.09%) As of 07/3/2025 02:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OPCH vs. HIMS, GH, RDNT, BTSG, SHC, PRVA, CON, SGRY, ADUS, and VCYTShould you be buying Option Care Health stock or one of its competitors? The main competitors of Option Care Health include Hims & Hers Health (HIMS), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Addus HomeCare (ADUS), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. Option Care Health vs. Its Competitors Hims & Hers Health Guardant Health RadNet BrightSpring Health Services Sotera Health Privia Health Group Concentra Group Holdings Parent Surgery Partners Addus HomeCare Veracyte Option Care Health (NASDAQ:OPCH) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations. Which has more volatility & risk, OPCH or HIMS? Option Care Health has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.02, suggesting that its stock price is 102% more volatile than the S&P 500. Do institutionals and insiders believe in OPCH or HIMS? 98.1% of Option Care Health shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 0.6% of Option Care Health shares are owned by company insiders. Comparatively, 13.7% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has higher earnings & valuation, OPCH or HIMS? Option Care Health has higher revenue and earnings than Hims & Hers Health. Option Care Health is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOption Care Health$5.00B0.99$211.82M$1.2424.25Hims & Hers Health$1.48B7.26$126.04M$0.6969.44 Does the media refer more to OPCH or HIMS? In the previous week, Hims & Hers Health had 64 more articles in the media than Option Care Health. MarketBeat recorded 71 mentions for Hims & Hers Health and 7 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.67 beat Hims & Hers Health's score of 0.21 indicating that Option Care Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Option Care Health 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Hims & Hers Health 12 Very Positive mention(s) 3 Positive mention(s) 50 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Neutral Do analysts prefer OPCH or HIMS? Option Care Health presently has a consensus target price of $35.50, indicating a potential upside of 18.06%. Hims & Hers Health has a consensus target price of $39.58, indicating a potential downside of 17.39%. Given Option Care Health's stronger consensus rating and higher possible upside, equities analysts plainly believe Option Care Health is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Option Care Health 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88Hims & Hers Health 3 Sell rating(s) 8 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.92 Is OPCH or HIMS more profitable? Hims & Hers Health has a net margin of 9.24% compared to Option Care Health's net margin of 4.12%. Hims & Hers Health's return on equity of 22.75% beat Option Care Health's return on equity.Company Net Margins Return on Equity Return on Assets Option Care Health4.12% 16.90% 7.00% Hims & Hers Health 9.24%22.75%15.51% SummaryOption Care Health and Hims & Hers Health tied by winning 8 of the 16 factors compared between the two stocks. Get Option Care Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPCH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OPCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OPCH vs. The Competition Export to ExcelMetricOption Care HealthMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.10B$3.91B$5.50B$9.01BDividend YieldN/A1.28%5.38%4.04%P/E Ratio22.7535.6227.6020.30Price / Sales0.99101.05368.81103.83Price / Cash18.9423.8136.6357.47Price / Book3.644.398.055.68Net Income$211.82M$189.47M$3.18B$249.13M7 Day Performance-6.76%-1.09%2.82%3.30%1 Month Performance-3.96%-3.76%3.70%5.20%1 Year Performance11.54%8.45%35.41%21.38% Option Care Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OPCHOption Care Health4.3729 of 5 stars$30.07-3.1%$35.50+18.1%+11.5%$5.10B$5.00B22.758,088Positive NewsHIMSHims & Hers Health2.2098 of 5 stars$42.09-34.5%$38.00-9.7%+134.1%$14.37B$1.48B149.351,637Trending NewsInsider TradeHigh Trading VolumeGHGuardant Health3.7629 of 5 stars$48.55-1.2%$53.76+10.7%+76.9%$6.09B$739.02M0.002,021Insider TradeRDNTRadNet3.6927 of 5 stars$54.87-0.7%$69.60+26.8%-5.2%$4.14B$1.83B-127.6011,021BTSGBrightSpring Health Services1.6399 of 5 stars$22.77+2.2%$24.90+9.4%+95.5%$3.92B$11.27B35.9235,000SHCSotera Health3.0173 of 5 stars$11.09-2.6%$15.80+42.5%+0.8%$3.23B$1.10B18.373,000PRVAPrivia Health Group4.2479 of 5 stars$21.61-1.1%$27.77+28.5%+30.4%$2.66B$1.74B182.081,140CONConcentra Group Holdings Parent2.5486 of 5 stars$20.95+1.0%$28.50+36.0%N/A$2.66B$1.90B15.3611,250SGRYSurgery Partners2.6276 of 5 stars$20.20+4.7%$33.56+66.1%-6.1%$2.47B$3.11B32.1715,000ADUSAddus HomeCare4.9661 of 5 stars$113.01-0.7%$142.57+26.2%-4.7%$2.09B$1.15B22.9949,703VCYTVeracyte3.619 of 5 stars$26.71+1.2%$40.90+53.1%+28.1%$2.07B$445.76M29.00790 Related Companies and Tools Related Companies Hims & Hers Health Alternatives Guardant Health Alternatives RadNet Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives Privia Health Group Alternatives Concentra Group Holdings Parent Alternatives Surgery Partners Alternatives Addus HomeCare Alternatives Veracyte Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OPCH) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Option Care Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Option Care Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
